カテゴリ： MarketLine, イギリス, 企業調査

Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務分析

◆英語タイトル：Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4495
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacturing and marketing of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various dosage forms such as solutions, suspensions and capsules and tablets. The company markets its products under brands such as Amoclan, Blopress, Suprax, Omnicef, Prograf, Suprax and Cresemba. The company primarily operates in the Middle East, North the US, Europe and Africa. The company is headquartered in London, the UK.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Hikma Pharmaceuticals PLC: Company Overview
Hikma Pharmaceuticals PLC: Overview and Key Facts
Hikma Pharmaceuticals PLC: Overview
Hikma Pharmaceuticals PLC: Key Facts
Hikma Pharmaceuticals PLC: Key Employees
Hikma Pharmaceuticals PLC: Key Employee Biographies
Hikma Pharmaceuticals PLC: Major Products and Services
Hikma Pharmaceuticals PLC: Company History
Hikma Pharmaceuticals PLC: Management Statement
Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Hikma Pharmaceuticals PLC: Key Competitors
Hikma Pharmaceuticals PLC: Company Analysis
Hikma Pharmaceuticals PLC: Business Description
Hikma Pharmaceuticals PLC: SWOT Analysis
Hikma Pharmaceuticals PLC: SWOT Overview
Hikma Pharmaceuticals PLC: Strengths
Hikma Pharmaceuticals PLC: Weaknesses
Hikma Pharmaceuticals PLC: Opportunities
Hikma Pharmaceuticals PLC: Threats
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity
Hikma Pharmaceuticals PLC: Financial Deals Overview
Hikma Pharmaceuticals PLC: Targets and Partners
Hikma Pharmaceuticals PLC: Top Deals 2016 – 2020YTD*
Hikma Pharmaceuticals PLC: Advisors
Hikma Pharmaceuticals PLC: Top Legal Advisors
Hikma Pharmaceuticals PLC: Mergers and Acquisitions
Hikma Pharmaceuticals PLC: Partnership
Hikma Pharmaceuticals PLC: Recent Developments
Hikma Pharmaceuticals PLC: News and Events Summary
Hikma Pharmaceuticals PLC: Contracts
Hikma Pharmaceuticals PLC: Corporate Governance
Hikma Pharmaceuticals PLC: Financial Deals
Hikma Pharmaceuticals PLC: Financial Performance
Hikma Pharmaceuticals PLC: Market Developments
Hikma Pharmaceuticals PLC: Research & Development
Hikma Pharmaceuticals PLC: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Company History
Table 4: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 5: Hikma Pharmaceuticals PLC: Key Competitors
Table 6: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 9: Hikma Pharmaceuticals PLC: Targets and Partners
Table 10: Hikma Pharmaceuticals PLC: Top Deals 2016 - 2020YTD*
Table 11: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 12: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: Hikma Pharmaceuticals PLC: News and Events Summary
Table 17: Hikma Pharmaceuticals PLC: Contracts
Table 18: Hikma Pharmaceuticals PLC: Corporate Governance
Table 19: Hikma Pharmaceuticals PLC: Financial Deals
Table 20: Hikma Pharmaceuticals PLC: Financial Performance
Table 21: Hikma Pharmaceuticals PLC: Market Developments
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

★海外企業調査レポート[Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bulgarian Energy Holding EAD：企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • China Mobile Limited：企業の戦略・SWOT・財務情報
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Iwatani Corporation (8088)：企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Meridian Bancorp, Inc. (EBSB)：企業の財務・戦略的SWOT分析
    Meridian Bancorp, Inc. (EBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Baoding Lightway Green Energy Technology Co Ltd-エネルギー分野：企業M&A・提携分析
    Summary Baoding Lightway Green Energy Technology Co Ltd (Lightway), a subsidiary of LONGJITAIHE Group, is a vertically integrated solar module manufacturer. It specializes in the manufacture of high quality solar PV products, provides professional solutions and customer service. The company develops …
  • Siemens Gamesa Renewable Energy S.A.：企業の戦略・SWOT・財務情報
    Siemens Gamesa Renewable Energy S.A. - Strategy, SWOT and Corporate Finance Report Summary Siemens Gamesa Renewable Energy S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • AMAG Pharmaceuticals Inc (AMAG)-製薬・医療分野：企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • I-Sens Inc (099190)：製品パイプライン分析
    Summary I-Sens Inc (i-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise blood glucose monitoring systems, electrolyte and gas analyzers, immuno sensors and accessories, among others. It provides blood monitoring systems …
  • The United India Insurance Co Ltd：企業の戦略・SWOT・財務情報
    The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Baloise Holding Ltd (BALN)：企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Citibank NA-India Branches：企業の戦略的SWOT分析
    Citibank NA-India Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ABM Industries Incorporated：企業の戦略・SWOT・財務分析
    ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report Summary ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cisco Systems Inc (CSCO)：電力：M&Aディール及び事業提携情報
    Summary Cisco Systems Inc (Cisco) designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products are blade switches, analytics and automation software, application networking services, interfaces and modules, optical networking, security, s …
  • Denator AB：医療機器：M&Aディール及び事業提携情報
    Summary Denator AB (Denator) is a provider of heat stabilization technology solutions that markets, develops, and sells instruments and consumables to address needs in the life science and clinical research markets. The company provides products such as stabilizor peptide extraction kits, stabilizor …
  • Janssen Pharmaceuticals Inc-医療機器分野：企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Memorial Health System：企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Shikoku Electric Power Co., Inc.：企業の戦略・SWOT・財務情報
    Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hologic, Inc.：企業のM&A・事業提携・投資動向
    Hologic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hologic, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Omnova Solutions Inc. (OMN)：企業の財務・戦略的SWOT分析
    Omnova Solutions Inc. (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Forty Seven Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆